Clin2
NCT06481852Possibly a fitRecruiting

Gut bacteria transplant for pulmonary arterial hypertension

Pulmonary Arterial Hypertension

Part of Lungs & breathing clinical trials.

This trial tests whether a special combination of antibiotics, fecal transplant (gut bacteria from healthy donors), and a fiber supplement can help people with pulmonary arterial hypertension (PAH). It aims to see if improving gut health can improve PAH symptoms and overall well-being.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
24 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have been diagnosed with pulmonary arterial hypertension (PAH) and are on a stable treatment plan for at least one month.
  • You can swallow capsules and provide blood and stool samples.
  • You are willing to follow the study schedule and can be contacted by phone, video, or in person.
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study.
  • You do not have conditions like active inflammatory bowel disease, severe irritable bowel syndrome, or a weakened immune system.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07751120Not yet recruiting· Phase 1
Gut bacteria transplant for pulmonary hypertension

This study tests whether transplanting healthy gut bacteria, after a short course of antibiotics and with fiber supplements, can improve symptoms of pulmonary hypertension. It is an early-phase trial to see if the treatment is safe and helpful.

Minneapolis, Minnesota
NCT07612657Not yet recruiting· Phase 3
Extended-Release Tacrolimus for Pulmonary Arterial Hypertension

This trial tests whether a new form of tacrolimus (a medication that helps calm the immune system) can improve breathing and exercise ability in people with pulmonary arterial hypertension (high blood pressure in the lungs) who are still limited despite current treatments. The study aims to see if this drug can help patients walk farther and feel less short of breath.

NCT07481981Recruiting· Phase 3
Study of once-daily inhaled TPIP for pulmonary arterial hypertension

This trial tests an inhaled medication (TPIP) that opens blood vessels in the lungs to help you breathe easier and be more active. It is for people with PAH who are already on stable treatment and have moderate symptoms.

Santa Barbara, California
NCT05464095Recruiting
Mobile health support for pulmonary arterial hypertension

This study tests whether using a mobile health tool can help people with pulmonary arterial hypertension (PAH) manage their condition in daily life. It’s aimed at adults who are stable on their PAH medicines and can track activity using a wearable device.

Nashville, Tennessee
NCT06747611Recruiting· Phase 2
Gut bacteria transplant for alopecia areata

This study tests whether transplanting healthy gut bacteria can help people with moderate to severe alopecia areata regrow hair. You will take antibiotics to prepare your gut, then receive the transplant through a colonoscopy or capsules.

Minneapolis, Minnesota
NCT07490054Recruiting· Phase 1
Fecal transplant for chronic heart failure

This trial tests whether transferring healthy gut bacteria (fecal microbiota transplant) can help people with chronic heart failure feel better and improve their heart function.

New York, New York

Hear when a new Pulmonary Arterial Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.